Vishal Bansal
Gründer bei Oxeia Biopharmaceuticals, Inc.
Profil
Vishal Bansal has founded Oxeia Biopharmaceuticals, Inc. in 2014, where he currently holds the title of Chief Scientific Officer.
He previously worked as a Professor at the University of California San Diego.
Dr. Bansal holds a doctorate degree from Wayne State University (Michigan) and an undergraduate degree from Kalamazoo College.
Aktive Positionen von Vishal Bansal
| Unternehmen | Position | Beginn |
|---|---|---|
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Gründer | 01.01.2014 |
Ehemalige bekannte Positionen von Vishal Bansal
| Unternehmen | Position | Ende |
|---|---|---|
| University of California San Diego | Corporate Officer/Principal | - |
Ausbildung von Vishal Bansal
| Kalamazoo College | Undergraduate Degree |
| Wayne State University (Michigan) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Health Technology |